Taylor Shane H, Arnold Nicole D, Biggs Lesley, Colloca Christopher J, Mierau Dale R, Symons Bruce P, Triano John J
J Can Chiropr Assoc. 2004 Mar;48(1):74-108.
Over the past decade, mechanical adjusting devices (MADs) were a major source of debate within the Chiropractors' Association of Saskatchewan (CAS). Since Saskatchewan was the only jurisdiction in North America to prohibit the use of MADs, the CAS established a committee in 2001 to review the literature on MADs. The committee evaluated the literature on the efficacy, safety, and uses of moving stylus instruments within chiropractic practice, and the educational requirements for chiropractic practice. Following the rating criteria for the evaluation of evidence, as outlined in the Clinical Guidelines for Chiropractic Practice in Canada (1994), the committee reviewed 55 articles - all of which pertained to the Activator. Of the 55 articles, 13 were eliminated from the final study. Of the 42 remaining articles, 6 were rated as class 1 evidence; 11 were rated as class 2 evidence and 25 were rated as class 3 evidence. In this article - the first in a series of two - the background and the methods utilized by the MAD committee's activities are described, as well as the results for the review of the literature on efficacy. Of the 21 articles related to efficacy, five were identified as Class 1 evidence; 4 were identified as Class 2 evidence; and 12 were identified as Class 3. Overall, the committee reached consensus that the MAD procedures using the Activator were as effective as manual (HVLA) procedures in producing clinical benefit and biological change. A minority report was also written, arguing that there was not enough evidence to support or refute the efficacy of MADs.
在过去十年中,机械调整装置(MADs)一直是萨斯喀彻温省脊骨神经疗法协会(CAS)内部争论的主要焦点。由于萨斯喀彻温省是北美唯一禁止使用MADs的司法管辖区,CAS于2001年成立了一个委员会,以审查有关MADs的文献。该委员会评估了关于在脊骨神经疗法实践中使用移动触笔器械的功效、安全性和用途,以及脊骨神经疗法实践的教育要求的文献。按照《加拿大脊骨神经疗法临床实践指南》(1994年)中概述的证据评估评级标准,该委员会审查了55篇文章——所有这些文章都与激活器有关。在这55篇文章中,有13篇被排除在最终研究之外。在剩下的42篇文章中,6篇被评为1级证据;11篇被评为2级证据,25篇被评为3级证据。在这篇文章——两篇系列文章中的第一篇——中,描述了MAD委员会活动的背景和所采用的方法,以及功效文献综述的结果。在21篇与功效相关的文章中,5篇被确定为1级证据;4篇被确定为2级证据;12篇被确定为3级证据。总体而言,委员会达成共识,认为使用激活器的MAD程序在产生临床益处和生物变化方面与手动(高速度低幅度调整,HVLA)程序一样有效。还撰写了一份少数派报告,认为没有足够的证据支持或反驳MADs的功效。